Clinical trials recruiting for Recurrent Malignant Solid Neoplasm
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Minnesota | 3 |
| Alabama | 2 |
| Arizona | 2 |
| Colorado | 2 |
| Florida | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Indiana | 2 |
| Massachusetts | 2 |
| Michigan | 2 |
| Missouri | 2 |
Top cities
Self-screener
Recruiting trials
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Related conditions
Trials recruiting for Recurrent Malignant Solid Neoplasm often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Recurrent Malignant Solid Neoplasm trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.